etidronate has been researched along with Asthma in 8 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
Excerpt | Relevance | Reference |
---|---|---|
"The study was designed to establish the effects of HRT on osteoporosis and fractures over five years in postmenopausal women with asthma receiving regular glucocorticoids and to compare with etidronate." | 9.14 | Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial. ( Campbell, IA; Douglas, JG; Francis, RM; Prescott, RJ; Reid, DM, 2009) |
" A randomised study was performed to determine whether treatment with cyclical etidronate and/or calcium for 5 years prevents fractures or reverses/reduces bone loss in patients receiving glucocorticoid treatment for asthma." | 9.11 | Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids. ( Campbell, IA; Douglas, JG; Francis, RM; Prescott, RJ; Reid, DM, 2004) |
"The study was designed to establish the effects of HRT on osteoporosis and fractures over five years in postmenopausal women with asthma receiving regular glucocorticoids and to compare with etidronate." | 5.14 | Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial. ( Campbell, IA; Douglas, JG; Francis, RM; Prescott, RJ; Reid, DM, 2009) |
" A randomised study was performed to determine whether treatment with cyclical etidronate and/or calcium for 5 years prevents fractures or reverses/reduces bone loss in patients receiving glucocorticoid treatment for asthma." | 5.11 | Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids. ( Campbell, IA; Douglas, JG; Francis, RM; Prescott, RJ; Reid, DM, 2004) |
"The results show that intermittent cyclical etidronate therapy with calcium and vitamin D supplementation significantly increases lumbar spine BMD in patients with osteoporosis resulting from long-term treatment with corticosteroids." | 5.08 | A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment. ( Li, F; Moniz, C; Pack, S; Pitt, P; Todd, P; Webber, D, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Campbell, IA | 2 |
Douglas, JG | 2 |
Francis, RM | 2 |
Prescott, RJ | 2 |
Reid, DM | 2 |
Ortego-Centeno, N | 1 |
Muñoz-Torres, M | 1 |
Callejas-Rubio, JL | 1 |
Riera-Montes, M | 1 |
Rolla, G | 1 |
Bucca, C | 1 |
Brussino, L | 1 |
Worth, H | 1 |
Stammen, D | 1 |
Keck, E | 1 |
Pitt, P | 1 |
Li, F | 1 |
Todd, P | 1 |
Webber, D | 1 |
Pack, S | 1 |
Moniz, C | 1 |
Goldstein, MF | 1 |
Fallon, JJ | 1 |
Harning, R | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
HRT and/or Etidronate in the Prevention and Treatment of Osteoporosis and Fractures in Post-Menopausal Patients With Asthma Receiving Long-Term Oral and/or Inhaled Glucocorticoids:a Randomised Factorial Trial[NCT00376662] | Phase 4 | 750 participants | Interventional | 1992-08-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for etidronate and Asthma
Article | Year |
---|---|
Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Alendronate; Asthma; Bone Density; Bone Rem | 1999 |
5 trials available for etidronate and Asthma
Article | Year |
---|---|
Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial.
Topics: Anti-Asthmatic Agents; Asthma; Bone Density Conservation Agents; Cohort Studies; Estrogen Replacemen | 2009 |
Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids.
Topics: Administration, Inhalation; Administration, Oral; Asthma; Bone Density; Calcium; Etidronic Acid; Fem | 2004 |
Etidronate and glucocorticoid induced osteoporosis.
Topics: Asthma; Bone Density; Budesonide; Drug Therapy, Combination; Etidronic Acid; Glucocorticoids; Humans | 2005 |
Therapy of steroid-induced bone loss in adult asthmatics with calcium, vitamin D, and a diphosphonate.
Topics: Adrenal Cortex Hormones; Asthma; Bone Density; Calcium; Drug Therapy, Combination; Etidronic Acid; F | 1994 |
A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.
Topics: Aged; Asthma; Bone Density; Calcium; Double-Blind Method; Drug Therapy, Combination; Etidronic Acid; | 1998 |
2 other studies available for etidronate and Asthma
Article | Year |
---|---|
[Asthma--prevention of glucocorticoid-induced osteoporosis with etidronate and calcium].
Topics: Asthma; Calcium; Etidronic Acid; Glucocorticoids; Humans; Osteoporosis | 2005 |
Bisphosphonate-induced bronchoconstriction in aspirin-sensitive asthma.
Topics: Aspirin; Asthma; Clodronic Acid; Etidronic Acid; Female; Humans; Middle Aged | 1994 |